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Background: The aim of this comparative study was to investigate the type and frequency of diagnoses preceding
adult bipolar disorder (BD) and schizophrenia (SZ).
Methods: A follow-back study of all preceding diagnoses in all patients aged 21–34 years with a primary, first time
diagnosis of BD (N = 784) or SZ (N = 1667) in 2008 to 2010. Data were taken from the Danish Psychiatric Central
Research Register (DPCRR) including ICD-10 and ICD-8 diagnoses.
Results: The numbers of patients with any preceding diagnoses amounted to 69.3% in BD and 76.6% in SZ with
affective disorders (excluding BD) being the most frequent preceding diagnosis (46.6 vs. 28.0%), followed by
psychoses (PSY) other than SZ (14.2 vs. 41.5%, p < .001), and substance use disorders (SUD) (16.1 vs. 26.9%, p < .001).
Reactions to severe stress were equally frequent in both samples (26.3 vs. 26.6%) as were personality disorders (21.8
vs. 22.4%) and ADHD (4.2 vs. 3.5%), whereas rates of conduct disorders (1.7 vs. 3.1%) were rather low in both
samples. Very few of the preceding diagnoses had their onset in childhood and adolescence. Overall patients with
SZ had a minor but statistically significant earlier onset of any psychiatric disorder compared to BD (mean age: 23.3
vs. 22.5, p < .001). Regression analyses indicated that BD was associated with an increased risk of having
experienced preceding affective disorders and ADHD, while SZ was associated with an increased risk of preceding
substance use disorders, psychosis, anxiety disorders, and personality disorders.
Conclusions: Specific developmental trajectories of preceding disorders were delineated for BD and SZ with
affective disorders being more specific for BD and both SUD and PSY more specific to SZ. There are different
patterns of vulnerability in terms of preceding diagnosis in young adults with BD and SZ.
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Studies in developmental psychopathology based on longi-
tudinal-epidemiological approaches have shown that adult
mental disorders are often preceded by various psychiatric
disorders originating in childhood or adolescence. For
instance, the longitudinal study of the Dunedin birth
cohort in New Zealand found that 74% of all adult psychi-
atric patients received a diagnosis before the age of 18 [1].
However, most of the existing literature failed to establish
a clear developmental perspective on diagnostic shifts and
continuities in the course of various psychiatric disorders* Correspondence: somaa@rn.dk
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reproduction in any medium, provided the orfrom adolescence to adulthood. Many studies report
lifetime prevalence rates of various diagnoses in specific
patient populations such as patients with Bipolar Disorder
(BD) or Schizophrenia (SZ), but fail to distinguish which
disorders occurred prior to, during, and following the
onset of the specific disorder. It should be noted, however,
that a clear distinction between concurrent comorbidity
and sequential comorbidity [2] is vital for a better under-
standing of the course of psychiatric disorders as patients
develop from childhood through adolescence to adulthood.
The following sketch of the literature will briefly
summarize studies on the sequential comorbidity as
well as studies investigating lifetime comorbidity in BD
and SZ. This brief review of preceding disorders will
firstly focus on the so-called disruptive or externalizingral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ered, and it will conclude with substance use disorders
and psychoses.
In the recent past, the most intensive debate in this
research domain has revolved around the issue of whether
or not Attention-Deficit/Hyperactivity Disorder (ADHD)
is a frequent misdiagnosis of early signs of BD, or whether
it is only comorbid to BD [3]. In the Oregon Adolescent
Depression Project (OADP) 11% of adolescents with BD
also had ADHD and 3.8% of adolescents with ADHD also
had BD [4]. Furthermore, in a large adult sample 19.4% of
those with ADHD also had BD and 21% of those with BD
also had ADHD [5]. However, conflicting comorbidity
rates were found in various cross-sectional community
studies [4-8] and due to low rates of BD in these studies,
the lack of a correlation between ADHD and BD should
be interpreted with caution [9]. Furthermore, multiple
studies have documented a high familial load of BD in
families with ADHD and vice versa [10]. In contrast, a
recent review of all prospective longitudinal studies on
the offspring of parents with BD showed that childhood
ADHD was not a reliable predictor of the development
of BD [11]. Thus, there are conflicting findings on the
co-occurrence of these two disorders.
Compared to BD, the debate on an association of
ADHD with SZ has been less intensive, but some studies
indicate that children and adolescents with ADHD are
also at increased risk of developing SZ compared to the
general population [12,13]. In a Danish register based
study, 3.8% of patients with ADHD developed SZ when
followed to the mean age of 31 years. In this study, child-
hood ADHD cases were compared to non- childhood
ADHD controls and the study identified an increased
risk of SZ equal to a relative risk of 4.3 (95% CI 1.9-
8.57) [13]. In addition, the findings from the Dunedin
birth cohort study indicate that ADHD for some pa-
tients precede schizophreniform disorders [1]. This
study found that ADHD in childhood/adolescence was
associated with adult schizophreniform disorders equal
to an odds ratio of 4.5 (CI 95% 1.8-11.0) compared to
cases who did not have the disorder in adulthood [1].
In addition to ADHD, other childhood disruptive be-
haviours such as conduct disorder (CD) and oppositional
defiant disorder (ODD) have been found in the history of
patients with either BD or SZ. Adult patients with BD have
been found to have a history of 30% of disruptive behaviour
disorders compared to only 5% in non-psychiatric controls
[14]. Furthermore, a prospective community study found
that patients with adult BD had a significantly increased
frequency of preceding disruptive behaviour disorders when
compared to community controls (42.9% vs. 11%) [15].
Aggressive behaviours have also been noted as precursors
for SZ in adulthood. As demonstrated in a large com-
munity based study, childhood or adolescent conductproblems predicted an increased risk for SZ in adult-
hood [17]. In another study on SZ based on 248 adult
males, CD with onset before the age of 15 was comorbid
to SZ in 21.3% of the sample. Furthermore, in this study
CD was associated with an earlier onset of SZ and
overall a more severe course [16]. However, conduct
problems have been shown to precede various adult
psychiatric disorders and are, therefore, not specific risk-
markers for developing either BD or SZ [1,17].
Further studies have dealt with anxiety disorders pre-
ceding either BD or SZ. Compared to non-psychiatric
controls, adult patients with BD have been found to have
an increased frequency of anxiety disorders prior to their
BD diagnosis (42% vs. 5%) [14]. An increased risk of ado-
lescent anxiety disorders in patients with BD has been also
found in another study comparing adults with BD with
community controls (57.1% vs. 6.0%) [15]. However, re-
gardless of the often observed anxiety disorders, the
Dunedin study failed to find an increased frequency of
childhood anxiety in patients with mania compared to
clinical controls [1]. Anxiety disorders are also frequent
concurrent and preceding comorbidities in SZ. A recent
meta-analysis of the lifetime and one-year prevalence
rates of anxiety disorders in SZ found that 38.3% of patients
with SZ fulfilled criteria for at least one co-morbid anxiety
disorder [18]. Finally, data from a high-risk study indicated
that social anxiety was one of the factors associated with
conversion to SZ [19].
In addition, various studies have shown that depressive
disorders often precede the onset of BD. The frequency
of adolescent depression in patients with adult BD in a US
community-based study was 28.6% compared to 7.0%
in the community controls [15]. In the Dunedin study,
patients with adult mania compared to clinical controls
had an increased frequency of juvenile depression equal
to an adjusted odds ratio of 3.3 (CI 95% 1.2-9.2) [1].
Juvenile depression was also associated with schizophre-
niform disorders in adulthood equal to an odds ratio of
7.4 (CI 95% 3.6-16.1) compared to patients who did
not develop the disorder [1]. As with anxiety disorders,
depressive disorders are frequent in both populations
of patients with SZ and BD with the risk of depression
exceeding the risk found in the general population [20].
Furthermore, there is some evidence that substance use
disorders (SUD) frequently precede BD and mania [21,22].
One study investigating the sequence of SUD in first-
episode bipolar I patients found that 45.2% met criteria
for SUD [21]. Another community based follow-up study
found that cannabis use predicted an increased risk for
later mania, but also that mania did not predict the onset
of cannabis use suggesting that substance use can act as
a trigger of BD behaviours [22]. This study found that
cannabis use increased the risk of mania onset (OR: 2.5
CI 95% 1.4-4.6) after controlling for a range of socio-
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have pointed to an association of preceding SUD and SZ
with a predominance of alcohol and cannabis use before
the onset of SZ [23,24] but the role of cannabis use in the
aetiology of SZ is still unclear [25].
Finally, psychosis may precede both BD and SZ. One
study following-up patients with first-episode psychosis
found that up to 12% of cases with non-affective psychosis
later developed BD [26]. Furthermore, an Italian study
found that among a population of 1081 first-episode BD
patients, 7.96% had preceding psychosis [27]. In a large
register-based study from Sweden, the authors found
that among patients presenting in psychiatry with a
first-episode of psychosis, 5% were diagnosed with BD
during a 5-year follow-up and 18% were diagnosed
with SZ [28]. Another prospective follow-up study of
patients presenting with first-episode psychosis found that
after a follow-up period of 10 years, 50% had developed
SZ and 16% had developed BD [29]. This finding suggests
that psychosis develops into SZ more often than BD, but
that conversion from psychosis to BD is not infrequent.
Aims of the study
In the present study, we examined whether the patterns of
preceding psychiatric disorders varied in patients diagnosed
with BD or SZ. This was done by studying the frequency of
lifetime preceding diagnoses in two nationwide groups
of patients diagnosed with BD or SZ for the first time at
the age of 21–34 years. In addition to studying the much
debated association of BD and ADHD we extended the
focus of research also to SZ and included further diagnoses
expected to be common clinical precursors to both BD
and SZ, namely, SUD, psychoses other than SZ, affective
disorders, anxiety disorders, reaction to stress, personal-
ity disorders, and CD. Apart from estimating lifetime
prevalence of preceding psychiatric disorders in the pa-
tient population, we were also interested in identifying
prevalence rates of these disorders in childhood and
adolescence.
Methods
Procedure
We used data from the Danish Psychiatric Central Research
Register (DPCRR) and the Danish Central Civil Registration
Register (DCR) in the present study. Registry studies
are made possible in Denmark, since all inhabitants in
Denmark are given a unique personal identification number
at birth allowing the identification of a given persons con-
tacts within the health care system across time. The Danish
society has enjoyed a well-fare model for decades where all
inhabitants get free and accessible treatment in both som-
atic and psychiatric treatment facilities in the public sec-
tor. DPCRR data is built on the activities in these Danish
psychiatric public hospitals, thus making registry data onhealth care a representative and nationwide source of data
on the health of the Danish population. The DPCRR
covers all contacts with the mental health care system
along with all psychiatric diagnoses, the date, and the
place of the diagnosis [30]. The DCR provided informa-
tion on ID-number, sex and date of birth. The study was
approved by the Danish Data Protection Agency, National
Board of Health and Statistics Denmark.
The current study was designed as a retrospective
longitudinal registry-based case–control study. Cases and
controls consisted of patients diagnosed for the first
time with BD (F31 in ICD-10) or SZ (F20 in ICD-10) in
Denmark in young adulthood. All patients who were
diagnosed solely in the emergency wards were excluded
from the analyses to strengthen the validity of the diagno-
ses. Cases and controls in the study were selected if they
were diagnosed at the age of 21–34 years in 2008–2010.
This limitation on age and year of diagnosis was chosen to
make the groups as homogenous as possible regarding the
age at onset of the disorders.
Patients were followed back from the date before their
first diagnosis of either BD or SZ to their time of birth to
calculate life time prevalence rates of mental disorders. The
decision to follow patients from the date preceding the first
diagnosis of BD and SZ was made to focus specifically on
the preceding psychiatric course so that preceding and
concurrent rates of comorbidity were not mixed. Because
the DPCRR has collected data on activities in the public
health care system of Denmark since 1969, the registry
has complete data covering all of the patients’ lifetime.
A total of N = 797 patients were diagnosed with BD and
N = 1,680 with SZ using these in- and exclusion criteria.
In 13 cases, the onset of BD and SZ co-occurred; these
cases were excluded leaving N = 784 patients in the
sample of BD patients and N = 1,667 patients in the SZ
sample.
We followed the cohort during both the ICD-8 and the
ICD-10 period in Denmark based on DPCRR data. Before
1994, the ICD-8 represented the official nosology in
Denmark. In 1994, the ICD-10 was introduced as the
official classification system. Although before 1995 only
inpatient contacts were registered, the data was included
to obtain the most complete account for all the years in
the patients’ lives.
Preceding diagnoses that were considered for analysis
in the present study included SUD (303, 304 in ICD-8; F10
in ICD-10), psychosis other than SZ (F21-29 in ICD-10),
affective disorders other than BD (296.0, 300.4 in ICD-8;
F32, F33, F34.1, F92.0 in ICD-10), anxiety disorders (300.0,
300.2 in ICD-8; F40, F41, F93 in ICD-10), reactions to se-
vere stress (307, 308.4 in ICD-8; F43 in ICD-10), personality
disorders (301 in ICD-8; F60 in ICD-10), ADHD (308.3 in
ICD-8; F90 in ICD-10), and CD (308.1, 308.1-2 in ICD-8;
F90.1, F91, F92 in ICD-10).
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Data on preceding diagnoses were used to calculate life-
time prevalence rates of psychiatric disorders in the two
groups. Chi-square tests were used to test for differences
of the preceding diagnoses in the BD and SZ sample.
Mann–Whitney U-tests were employed for the analysis of
age at diagnosis of the preceding disorders because data
was not normally distributed. To investigate the effect of
sex on the risk of having the various preceding diagnoses
in the population a series of binary logistic regression ana-
lyses were carried out. In these analyses the outcome was
specified as the preceding diagnosis of interest and the co-
variate in the model was sex (females as reference group)
and analyses were controlled for age. Since we suspected
that year of birth was strongly related to the risk of having
a preceding diagnosis of e.g. ADHD we carried out a series
of Cox regression analyses with the various preceding
diagnoses as the events (outcome), time being the time
from birth to the first time diagnosis of the specific pre-
ceding disorder and censoring occurring at the first time
diagnosis of BD/SZ. This was done to control for the
variation in follow-up time experienced by patients. The
variable for year of birth included in the model was di-
chotomized such that patients were categorized as born
before or after 1980. Patients born before 1980 served as
the reference group in these analyses and the models were
controlled for sex. To evaluate if any of the lifetime pre-
ceding disorders predicted a higher risk of either BD or
SZ crude and age/sex-adjusted odd ratios were calculated
using binary logistic regression analyses. In these analyses
BD/SZ were the outcome and the preceding diagnoses,
sex and age the co-variates. All analyses were done using
IBM SPSS statistics 19th edition.
Results
A flow-chart of the identification of the patients in the
present study is provided in Figure 1. There were signifi-
cantly different sex distributions in the samples with more
females in the BD sample (N= 484 [61.7%] females vs. N =
300 [38.3%] males) (Chi2 = 43.2, df = 1; p = <0.001) and sig-
nificantly more males in the SZ sample (N= 1.073 [64.4%]
males vs. N = 594 [35.6%] females) (Chi2 = 137.6, df = 1; p =
<0.001). The mean age at diagnosis of BD was 27.8 (SD=
4.0) years and it was 26.3 (SD= 4.1) years in the SZ sample.
Age at first time diagnosis differed significantly between
patients diagnosed with BD or SZ (Z = −8.6; p < 0.001).
In the two cohorts, N = 543 (69.3%) patients diagnosed
with BD and N= 1,277 (76.6%) patients diagnosed with SZ
had a preceding diagnosis. Lifetime preceding psychiatric
disorders and preceding psychiatric disorders with onset in
childhood and adolescence are shown in Table 1. Lifetime
prevalence rates were high for preceding SUD (26.9%) and
psychoses (41.5%) in SZ and for preceding affective disor-
ders (46.6%) in BD. All prevalence rates of precedingdisorders including ADHD and CD in particular were
low during childhood and adolescence in both samples.
As seen in the lifetime frequencies in Table 1, preceding
SUD in particular, due to cannabis use disorders, psychoses,
schizoid and antisocial personality disorders, and CD were
observed significantly more in SZ patients. Affective disor-
ders and, in particular, mania and depressive disorders were
significantly more frequent in BD patients. However, there
was little differentiation of the two samples in terms of
preceding disorders originating in childhood and adoles-
cence. Only cannabis use disorder was significantly more
common in SZ than in BD in this period.
Comparisons of the age of first time diagnosis of the pre-
ceding disorder for the major groups of disorders are shown
in Table 2. The findings indicate that SZ was associated
with a significantly earlier onset of preceding affective disor-
ders, reactions to severe stress, and personality disorders.
The results of the effect of birth year and sex on the
risk of having the various preceding diagnoses are pre-
sented in Table 3, and the effect of the various comorbid
disorders on the risk of BD/SZ is presented in Table 4.
Male sex was a risk factor for SUD, psychosis and
ADHD, while female sex was a risk factor for affective
disorders, anxiety disorders, reactions to severe stress
and personality disorders. There were significant effects
on the risk of the preceding disorders associated with
year of birth with persons born after 1980 having an ele-
vated risk of being diagnosed with all psychiatric disor-
ders. Most pronounced was the effect for ADHD and
conduct disorder when controlling for length of follow-
up time (Table 3). The adjusted models showed that
ADHD was weakly associated with an increased risk for
BD compared to SZ (Table 4). Preceding affective disor-
ders were strongly associated with BD whereas SUD,
psychoses, anxiety disorders and personality disorders
increased the risk of SZ compared to BD. No differences
were found for risk of diagnosis of BD compared to SZ
for reactions to severe stress and conduct disorder.
Discussion
First, preceding psychoses and SUD differed for BD and
SZ. These disorders were associated with later SZ com-
pared to BD patients, even after controlling for sex
which is a known confounder for both psychoses and
SUD. These findings are in line with expectations as
psychoses are known to be precursors for SZ and SUD
have been documented as a risk factor for psychoses.
Therefore they are inherently also a risk factor for SZ
[23,24,31]. Although psychoses and SUD have been docu-
mented as frequently occurring disorders in patients de-
veloping BD or SZ [21,22,26,27,29] in the present study
the association was stronger for SZ and thus, may serve as
evidence for differentiating preceding psychiatric histories
of patients with BD or SZ.
All diagnosed pts. 
In DPCRR
N= 531.203
All patients with  SZ
N= 44.693
Pts. having a 
previous 
diagnosis 
N=543
Pts. having a 
previous 
diagnosis
N=1.277
• Substance use disorder: N=126
• Psychosis: N=111
• Affective disorders: N=365
• Anxiety disorders: N=69
• Reactions to severe stress: N=206
• Personality disorders:N=171
• ADHD: N=33
• Conduct disorders: N=13
All patients with BD
N= 56.444
All patients with BD 
excluding emergency 
contacts
N= 55.183
All patients with SZ 
excluding emergency 
contacts
N= 43.081
BD patients diagnosed 
2008-2010 age 21-34
N= 797
SZ patients diagnosed 
2008-2010 age 21-34
N= 1.680
Overlapping BD/SZ 
cases N=13
excluded
Final SZ sample 
N=1.667
Final BD sample 
N=784
• Substance use disorder: N=449
• Psychosis: N=691
• Affective disorders: N=466
• Anxiety disorders: N=187
• Reactions to severe stress: N=444
• Personality disorders:N=374
• ADHD: N=56
• Conduct disorders: N=52
Figure 1 Flowchart.
Andersen et al. BMC Psychiatry 2013, 13:343 Page 5 of 10
http://www.biomedcentral.com/1471-244X/13/343Furthermore, after correcting for the confounding effect
of the various co-variates included in the regression
models, preceding anxiety disorders were also significantly
associated with SZ with 11% of the affected patients hav-
ing been diagnosed with an anxiety disorder preceding the
first time diagnosis of SZ. This rate is lower than the find-
ings of previous studies as indicated by a recent meta-
analysis which calculated a prevalence rate of 38.3% for
anxiety disorders in patients with SZ [18]. The prevalence
rates for anxiety disorders in patients with BD were also
lower in the present study than the findings from other
studies [14,15]. Two major explanations may help to
understand the divergence in findings. First of all, the
present study solely reported anxiety disorders preced-
ing SZ and BD and hence, the prevalence is expected to
be lower than in studies where prevalence rates of anx-
iety were aggregated for concurrent and preceding
diagnoses. Secondly, many anxiety disorders may have
been treated in the primary sector by general practi-
tioners as long as they were uncomplicated or nottreatment- resistant. The present study only documented
rates of anxiety disorders that were severe enough to
have warranted referral to the psychiatric hospitals. When
comparing the present findings to previous studies in terms
of its differential impact of predicting SZ but not BD, there
is some similarity to the findings from the Dunedin studies,
which found that anxiety disorders were more frequent
among patients who developed schizofreniform disorders
whereas anxiety disorders were not associated with adult
mania [1]. An increased risk for SZ compared to BD was
also found for personality disorders. The nature of this
finding is unclear. Future analyses might investigate how
often the diagnoses of personality disorders are preceding
diagnoses only and how many continue to be diagnosed
as concurrent comorbid disorders even after the diagnoses
of BD and SZ has been established.
Differences in the trajectories of preceding disorders
of BD and SZ were found also for the affective disorders.
Although affective disorders have frequently been docu-
mented in patients with SZ [20], they were a stronger
Table 1 Lifetime preceding psychiatric disorders and preceding psychiatric disorders with onset in childhood and
adolescence in BD and SZ
Lifetime preceding psychiatric disorders Preceding psychiatric disorders with onset before age 18
BD SZ BD SZ
N % N % x2 p N % N % x2 p
Substance use disorders 126 16.1 449 26.9 35.0 <.001 9 1.1 26 1.6 0.6 .423
Alcohol 60 7.7 136 8.2 0.2 .667 1 0.1 3 0.2 0.0 .764
Cannabis 48 6.1 271 16.3 48.4 <.001 2 0.3 18 1.1 4.5 .034
Opiods 9 1.1 33 2.0 2.2 .139 0 0 0 0 - -
Psychosis 111 14.2 691 41.5 180.4 <.001 14 1.8 35 2.1 0.3 .605
Affective disorders 365 46.6 466 28.0 82.3 <.001 15 1.9 46 2.8 1.6 .210
Mania 34 4.3 13 0.8 35.9 <.001 1 0.1 1 0.1 0.3 .585
Depressive disorders 325 41.5 450 27.0 51.6 <.001 14 1.8 42 2.5 1.3 .257
Anxiety disorders 69 8.8 187 11.2 3.3 .068 5 0.6 14 0.8 0.3 .595
Reactions to severe stress 206 26.3 444 26.6 0.0 .851 23 2.9 62 3.7 1.0 .321
Acute stress reaction 30 3.8 47 2.8 1.8 .182 2 0.3 3 0.2 0.1 .701
PTSD 10 1.3 41 2.5 3.7 .055 0 0 1 0.1 0.5 .493
Adjustment disorder 149 19.0 307 18.4 0.1 .727 17 2.2 48 2.9 1.0 .307
Personality disorders 171 21.8 374 22.4 0.1 .729 13 1.7 39 2.3 1.2 .275
Paranoid 4 0.5 10 0.6 0.1 .783 0 0 0 0 - -
Skizoid 2 0.3 26 1.6 8.0 .005 0 0 1 0.1 0.5 .493
Antisocial 6 0.8 34 2.0 5.4 .020 2 0.3 5 0.3 0.0 .846
Borderline 87 10.7 159 9.5 0.8 .363 6 0.8 15 0.9 0.1 .736
ADHD 33 4.2 56 3.5 0.8 .373 9 1.1 12 0.7 1.2 .283
Conduct disorder 13 1.7 52 3.1 4.4 .036 9 1.1 34 2.0 2.5 .117
Any preceding disorder 543 69.3 1277 76.6 15.0 <.001 67 8.5 176 10.6 2.4 .120
BD = bipolar disorders; SZ = schizophrenia; ADHD = attention deficit hyperactivity disorder.
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homotypic association may well have been the first epi-
sode of BD manifesting as depression before any
episode of mania or hypo-mania had been diagnosed.
The finding is in accordance with that from a USTable 2 Age at first time diagnosis of preceding disorders in
BD
Mean Median SD Ran
Substance use disorders 24.3 24.0 4.9 [14;
Psychosis 23.5 23 4.9 [14;
Affective disorders 25.0 25.0 4.5 [13;
Anxiety disorders 24.1 24.0 4.6 [11;
Reactions to severe stress 23.5 23.0 5.1 [10;
Personality disorders 23.5 24.0 4.6 [12;
Conduct disorder 18.9 16.0 7.1 [11;
ADHD 21.0 22 8.4 [3;3
Conduct disorder 18.9 16.0 7.1 [11;
Age at first preceding diagnosis 23.3 23.0 5.2 [3;3
BD = bipolar disorders; SZ = schizophrenia; ADHD = attention deficit hyperactivity dicommunity study indicating continuity between ado-
lescent depression and young adult BD [15] and the
finding of the Dunedin birth cohort study indicating
some continuity of juvenile depression and young adult
mania [1].BD and SZ
SZ
ge Mean Median SD Range z p
33] 23.4 22.0 4.9 [14;33] - 1.8 .067
34] 24.3 24.0 4.6 [5;34] - 1.8 .076
34] 23.4 23.0 4.7 [11;34] - 4.9 <.001
34] 23.2 23.0 4.5 [6;34] - 1.5 .134
34] 22.6 22 5.0 [9;34] - 2.2 .027
34] 22.6 22.0 4.4 [12;34] - 2.1 .035
32] 15.6 15.0 6.4 [5;30] −1.4 .168
3] 22.2 23.0 7.1 [5;33] - 0.6 .530
32] 16.0 16.0 6.3 [5;30] −1.1 .278
4] 22.5 22.0 5.1 [5;34] −3.2 .001
sorder.
Table 3 Sex and birth cohort as predictive for the risk of various preceding comorbid disorders in patients with
Bipolar disorder/Schizophrenia
Risk associated with sex* Risk associated with birth cohort**
OR CI95% p-value HR CI95% p-value
Substance use disorders 3.2 2.6 - 3.9 <.001 2.4 2.0 - 3.0 <.001
Psychoses 1.5 1.3 - 1.8 <.001 3.3 2.8 - 4.0 <.001
Affective disorders 0.4 0.4 - 0.5 <.001 3.2 2.7 - 3.8 <.001
Anxiety disorders 0.6 0.5 - 0.8 <.001 2.9 2.2 - 4.0 <.001
Reactions to stress 0.6 0.5 - 0.7 <.001 3.2 2.6 - 3.9 <.001
Personality disorders 0.6 0.4 - 0.6 <.001 1.8 1.5 - 2.2 <.001
CD 1.5 0.9 - 2.4 .159 11.3 4.1 - 31.1 <.001
ADHD 2.4 1.5 - 3.9 <.001 7.4 3.7 - 14.9 <.001
* Reference group: females. ** Reference group: persons born before 1980. HR= Hazard Ratio, OR= Odds Ratio.
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associated with BD than SZ was ADHD, although the
specific associations were less strong than the findings for
affective disorders. Considering the recent debate in the
research literature about whether BD in childhood might
often be mistaken for ADHD [3], the rather low preva-
lence of 4.2% of patients with ADHD prior to BD in the
present study is also noteworthy. This rate is just about
equal to the prevalence of ADHD in some US community
studies ranging between 1.9% and 5.7% for adolescents
[4,8] and amounting to 4.4% in adults [5] but it is higher
than in other studies [6-8]. If ADHD was a strong risk
factor for BD, a higher prevalence should have been
observed in the current study. Thus, the present
finding is not in accordance with a review concluding
that individuals with BD also seem to have high rates of
ADHD [9], and a recent study finding high rates of
concurrent and lifetime ADHD in a sample of BD patients
using retrospective assessments, whereby 19% of the
subjects screened positively for high rates of ADHD
symptoms [32].Table 4 Comorbid disorders as predictors for Schizophrenia/B
SZ BD
Crude
OR CI 95% OR CI 95%
Substance use disorders 1.9 1.5 - 2.4 0.5 0.4 - 0.6
Psychoses 4.3 3.4 - 5.4 0.3 0.2 - 0.3
Affective disorders 0.4 0.4 - 0.5 2.2 1.8 - 2.7
Anxiety disorders 1.3 1.1 - 1.8 0.8 0.6 - 1.0
Reactions to stress 1.0 0.8 - 1.2 1.0 0.8 - 1.2
Personality disorders 1.0 0.8 - 1.3 1.0 0.8 - 1.2
CD 1.9 1.0 - 3.5 0.5 0.3 - 1.0
ADHD 0.8 0.5 - 1.3 1.2 0.8 - 1.9
* Adjusted for sex and age at BD/SZ diagnosis. OR= Odds Ratio.However, the nature of the present study cannot rule
out the possibility that the association of BD and ADHD
could have been stronger because there were time/co-
hort effects. Thus, it may well be that not all BD and SZ
patients with ADHD had been identified and/or correctly
diagnosed in the public mental health system in the total
time period under investigation. Many cases in the study
had been born, and were children in a time-period when
ADHD was under recognized due to its non-specific
diagnostic criteria in the ICD-8 classification for ADHD.
Furthermore, as in most other countries, ADHD has
only in the recent past become a disorder that is well
recognized and diagnosed also in adults in Denmark.
Although the literature documents an increased oc-
currence of CD in patients developing either BD or SZ
as compared to the general population [14,17], the
present study found no increase in risk for patients who
developed BD in adulthood compared to those who de-
veloped SZ. As observed for ADHD, the prevalence
rates for CD in both BD and SZ were lower than ex-
pected from previous studies that found preceding CDipolar disorder
SZ BD
Adjusted*
p-value OR CI 95% OR CI 95% p-value
<.001 1.6 1.3 - 2.0 0.6 0.5 - 0.8 <.001
<.001 4.5 3.6 - 5.7 0.2 0.2 - 0.3 <.001
<.001 0.5 0.4 - 0.7 1.9 1.5 - 2.2 <.001
.069 1.5 1.1 - 2.0 0.7 0.5 - 0.9 .008
.851 1.2 1.0 - 1.4 0.9 0.7 - 1.1 .139
.739 1.4 1.1 - 1.7 0.7 0.6 - 0.9 .003
.039 1.4 0.8 - 2.7 0.7 0.4 - 1.3 .262
.373 0.6 0.4 - 0.9 1.6 1.1 - 2.6 .033
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[15-17]. However, cohort and time effects might have
played a role in the present analysis.
In terms of the few similarities of the patterns of preced-
ing disorders, reactions to stress was equally common in
both samples of BD and SZ. Most probably, the reactions
to stress reflect a generally heightened vulnerability of pa-
tients who later develop either BD or SZ.
In additional analyses, we looked at the manifestations
of preceding disorders in childhood and adolescence and
at the age at onset of these disorders. Whereas the rates
of preceding disorders were quite frequent across the
lifetime, they were rather low for all disorders originating
in childhood and adolescence. In general, the mean age at
onset was high, especially for disorders which are often di-
agnosed in childhood and early adolescence such as ADHD
and CD. The mean age for first time diagnosis of any of the
psychiatric disorders was 23 years for BD patients and
22.5 years for SZ patients. Preceding affective disorders,
reactions to stress, and personality disorders were diag-
nosed earlier in SZ than BD and thus, may have contrib-
uted to an earlier vulnerability in SZ. The latter finding
may be seen in line with the neurodevelopmental hypoth-
esis of SZ assuming that both SZ and BD occupy a gradient
with SZ reflecting a higher severity of neurodevelopmental
impairment than BD [33].
The findings of both a relatively high age at first time
diagnosis of any psychiatric disorders and of low frequen-
cies of psychiatric disorders in childhood and adolescence
do not necessarily indicate that a large number of disorders
went unnoticed or unrecorded. They may also point to a
sizeable number of subjects showing unclear preceding
psychopathological phenomena in childhood and adoles-
cence that may not exactly have met defining diagnostic
criteria, but might later have been considered as prodromal
features of a disorder. In addition, the results might also be
explained by the before mentioned cohort/period effects.
For all disorders, there were significant effect of year of
birth with strongly increased hazard ratios starting with
the year of birth in 1980 and onwards. This period matches
the time when all preceding disorders in the lives of
these patients had been diagnosed exclusively according to
ICD-10-criteria which had been introduced in Denmark
in 1994. Thus, classification effects may have been operat-
ing with the more detailed definition of disorders in the
ICD-10 compared to the ICD-8 perhaps having led psychi-
atrists to diagnose an increasingly higher rate of disorders
since the introduction of the ICD-10. Furthermore, the
findings could be explained by the lack of registrations of
outpatient contacts before 1995.
However, not only changes in the classification and
registration may explain the findings of cohort-time ef-
fects, because incidence rates of various disorders have
been found to increase in the ICD-10 period. This wasfound for e.g. depression, anxiety disorders, autism
spectrum disorders and ADHD in a series of papers inves-
tigating the time trends in incidence rates of diagnosed
mental disorders between 1995 and 2010 based on nation-
wide data-analysis using data from the DPCRR, by two of
the authors of the present study. The observed increases
in diagnosed incidence rates of mental disorders in the
Danish population might have been both due to increases
in the rates of psychiatric morbidity in the population and
due to an increased awareness for mental disorders in
both laymen and health care professionals leading to
higher referral rates to psychiatry.
In terms of the clinical implications, it is noteworthy
that a sizeable proportion of patients diagnosed in 2008–
2010 for the first time with BD or SZ, namely 69.3% and
76.6%, had a preceding psychiatric diagnosis. In particular,
the study presented additional evidence that patients with
affective disorders should be thoroughly assessed for
emerging symptoms of BD and patients with SUD and
psychosis should be considered to be at risk for SZ.
The study further documents that despite some shared
genetic vulnerability, the developmental trajectories of
BD and SZ are more different rather than similar in terms
of preceding mental disorders.
Among limitations of the present study it has to be
considered that all data stem from a register with a large
number of clinicians from different institutions and regions
contributing to the diagnoses over long time periods. First,
all data reflect diagnoses as recorded in the psychiatric
register implying that first manifestations of the disorder
or sub-threshold symptoms of the disorder may have oc-
curred earlier. Referral to and assessment within psychiatric
services may have occurred later after patients experienced
deficits in psychosocial functioning or had been in primary
care before entering the psychiatric service system. Sec-
ondly, although the ICD-8/10 systems provides inter-
national comparability of diagnoses, the Danish data may
to some extent reflect specific cultural attitudes towards
using the various categories of the classification systems
in clinical practice. However, these potential effects are
largely unknown as long as there are no comparative stud-
ies based on large registers, which rarely exist outside the
Scandinavian countries. Thus, the generalizability of the
findings in the present study to other countries is difficult
to evaluate. However, clinical assessments in Danish psy-
chiatric hospitals are thorough and are completed over
several assessment sessions by highly educated health care
professionals in an interdisciplinary collaboration ensuring
high quality of the psychiatric assessments.
Thirdly, as with all register studies the validity of the
diagnoses is a critical issue. Various studies based on the
DPCRR have shown that, in general, the validity of the
diagnoses is high. This is documented for childhood autism
[34], schizophrenia [35], and adult affective disorders [36].
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anxiety disorders in the DPCRR have been performed.
Even when considering these limitations, the relevance
of the present findings should not be under-estimated
since the alternative approach of prospective community
studies analysing the preceding diagnoses of BD and SZ
has not received sufficient research attention and/or is
fraught with other limitations, including the size and
representativeness of the sample. Furthermore, due to
the rarity of both BD and SZ in the general population the
course leading to the onset of these disorders is rather
difficult to study prospectively in unselected populations.
Conclusion
In the present study, two representative nationwide groups
of patients with primary diagnoses of either BD or SZ in
young adulthood were followed back to identify their
preceding psychiatric diagnoses. The present study differs
from all previous studies on comorbidity in BD and SZ
by its emphasis on studying co-morbid mental disor-
ders preceding the first time diagnosis of BD and SZ. A
majority of patients diagnosed with BD and SZ had a
psychiatric history preceding their first diagnosis of BD
or SZ (69.3% and 76.6%) reflecting that both BD and
SZ are serious mental disorders that gradually unfold.
Furthermore, there were more differences rather than
similarities in the patterns of preceding disorders of BD
and SZ.
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